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Epinephrine administration 
via a laryngeal mask airway: 
what is the optimal dose?
ABSTRACT
Background. The aim of this animal study was to clarify the effects of laryngeal mask airway (LMA)-administrated epineph-
rine and to assess the optimal dose.
Methods. Thirty pigs were anesthetized and intubated with a cuffed tracheal tube (TT) and an LMA. Then they were assigned 
to one of five groups. The control group received distilled water 10 mL via the TT; the TT group received epinephrine 50 g/
kg via the TT; and the other three groups received two, four or six times the TT dose of epinephrine via the LMA. Heart rate 
(HR) and arterial pressure were monitored before and after drug administration for 15 minutes.
Results. After epinephrine administration, the LMA-6 and TT groups had elevated systolic, diastolic and mean arterial pres-
sures at 1 min and there was no significant difference between the two groups. In the TT group, these parameters peaked 
at 2 min then declined rapidly. In the LMA-6 group, they increased more slowly, and then maintained a plateau. The control, 
LMA-2 and LMA-4 groups failed to display significant persistent (>2 min) hemodynamic changes.
Conclusions. We could not identify an optimal LMA-administrated epinephrine dose. The TT route is suitable when a high 
peak drug effect is required and the LMA route may be preferable if a persistent plateau effect is desired. Effective LMA 
administration of drugs may require larger doses than those given via TT.
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Introduction
Laryngeal mask airways (LMA) are 
widely used in anaesthesia and resus-
citation. (1,2) They are easy to use and 
require minimal training, which makes 
them an excellent alternative airway 
device for personnel who are not famil-
iar with airway management. (3-5)
Health care workers have been giv-
ing drugs through airway devices for 
decades. (6) Among these devices, the 
tracheal tube (TT) is most commonly 
used. However, considerable training 
is required to acquire and maintain the 
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skill of tracheal intubation. (7) Our previ-
ous studies revealed that using a cath-
eter inserted through an LMA into the 
trachea to deliver drugs is as effective 
as using the TT route. (8,9) However, 
the ease of passing a catheter and 
documenting its correct position are 
still under investigation. (10,11)
Trevisanuto et al. and Spain et al. 
reported that delivering surfactant and 
bronchodilator via an LMA is effective 
in treating neonatal respiratory distress 
syndrome and bronchospasm, respec-
tively. (12,13) Our previous studies 
showed that LMA-administered epine-
phrine was well absorbed through the 
mucosa of the airway but that, com-
pared with the TT route, the same dose 
produced a lower plasma level. (8,9) 
The optimal LMA-administered dose 
of epinephrine is unknown. We there-
fore gave increasing doses of LMA-
administered epinephrine to identify a 
dose equipotent to a standard TT dose 
and to clarify the characteristics of drug 
absorption via this route.
Materials and Methods
The Animal Care and Users Committee 
of the Chi-Mei Medical Center approved 
the study and the animals were cared 
for in accordance with national and 
institutional guidelines.
Thirty domestic Yorkshire pigs, nine 
males and 23 females, weighing 16.5–
27 kg were anesthetized with intrave-
nous pentothal 30 mg/kg and randomly 
assigned to one of five groups:
Control Group: 10 mL of distilled water 
via the TT.
TT Group: epinephrine 50 g/kg via 
the TT.
LMA-2 Group: epinephrine 100 g/kg 
via the LMA (twice the TT group dose).
LMA-4 Group: epinephrine 200 g/kg 
via the LMA (four times the TT group 
dose).
LMA-6 Group: epinephrine 300 g/kg 
via the LMA (six times the TT group 
dose).
All doses of epinephrine were diluted 
to a total volume of 10 mL with dis-
tilled water. The animals were intubated 
with a cuffed TT (internal diameter 5 
mm) and size 3 LMA (LMA-ClassTM, 
Laryngeal Mask Company, Henley on 
Thames, UK) (figure 1). We used a 
fibre-optic bronchoscope to confirm 
the position of the TT and to ensure that 
the opening of the larynx faced directly 
towards the lower aperture of the LMA. 
The animals were ventilated via the TT 
with a respiratory rate of 15 breath/min, 
tidal volume 20 mL/kg and FiO2 1.0. All 
animals were attached to a three-lead 
ECG monitor and given an infusion of 
0.9% normal saline solution at 20 mL/h 
throughout the experiment. A carotid 
or femoral catheter was inserted for 
continuous heart rate (HR) and arte-
rial blood pressure (BP) monitoring. An 
intravenous flush of heparin 3000 IU 
was given to avoid intra-catheter clot 
formation.
To achieve steady state conditions, a 
20-min stabilization period followed the 
completion of the above procedures. 
We recorded baseline HR and BP. Sub-
sequently, we deflated the cuff of the TT 
in the LMA-2, LMA-4 and LMA-6 groups 
to facilitate spraying epinephrine into 
the trachea through the LMA. In the 
control and TT groups, epinephrine and 
distilled water were delivered via the TT 
and in the other groups via the LMA. 
Drug administration was followed by 
five forceful artificial respirations using 
an Ambu Bag. The cuff of the TT was 
re-inflated after epinephrine adminis-
tration in the LMA groups. HR and BP 
were recorded continuously for 15 min 
following medication delivery. At the 
end of the experiment, the animals were 
killed by injection of potassium chloride 
solution 10 mEq. The methods of medi-
cation administration are presented in 
figure 1; all other procedures are illus-
trated in figure 2.
All experimental results are presented 
as medians unless otherwise noted 
(table 1).
The differences in HR and BP between 
the five groups were compared using 
the Kruskal-Wallis followed by Mann-
Whitney U tests. The intra-animal chang-
es in hemodynamic variables were inves-
tigated using the Wilcoxon signed rank 
test. All statistical tests were performed 
at a two-tailed significance level of 0.05.
Table 1. Biometric data.
Group Control TT LMA-2 LMA-4 LMA-6
Number of animals 
(M/F)
6 (2/4) 6 (2/4) 6 (3/3) 6 (1/5) 6 (1/5)
Weight 
(kg, mean±SD)
21.6±3.5 21.1±3.0 22.9±3.1 21.2±2.3 21.6±2.2
LMA, laryngeal mask airway; TT, tracheal tube.
Figure 1. In the control and TT gro-
ups, epinephrine was given via the TT 
(upper picture). In the LMA-2, LMA-4 
and LMA-6 groups, epinephrine was 
given via the LMA (lower picture).
LMA, laryngeal mask airway; TT, tra-
cheal tube.
AP, arterial pressure; HR, heart rate; 
LMA, laryngeal mask airway; TT, tra-
cheal tube.
Figure 2. Timeline for the experimen-
tal protocol. *Inflate and deflate TT 




There were no significant differences in 
biometric data between the five groups 
(table 1). The hemodynamic changes 
following epinephrine administration via 
the TT or LMA are illustrated in figures 
3-6.
The LMA-6 and TT groups had an 
increase in systolic arterial pressure 
(SAP) at 1 min post-injection (p=0.028, 
both groups). The response lasted for 
11 min and 8 min, respectively. The 
TT group had the highest peak SAP, 
at 2 min post-injection. However, the 
increase in SAP lasted longer in the 
LMA-6 group. There was no signifi-
cant difference between the two groups 
(p=0.605).
Both the LMA-6 and TT groups had 
significant elevations in diastolic arterial 
pressure (DAP) 1–7 min and in mean 
arterial pressure (MAP) 1–8 min post-
injection, respectively. Similarly, the TT 
group reached the highest peak DAP 
and MAP at 2 min after epinephrine 
administration. There was no signifi-
cant difference between the groups 
(p=0.629 in DAP and p=0.642 in MAP).
The HR increased in the TT group at 0.5 
min and in the LMA-6 group at 1 min 
post-injection (p=0.028 and p=0.046, 
respectively). The effect persisted for 
15 min in both groups. The TT group 
had the highest HR at 2 min. There was 
a significant difference between the two 
groups (p=0.01).
The control, LMA- and LMA-4 groups 
failed to display significant persistent 
(>2 min) hemodynamic changes after 
epinephrine administration.
Discussion
We tested increasing doses of LMA-
administrated epinephrine and com-
pared the effect with the standard tra-
cheal route. After epinephrine adminis-
tration, both the LMA-6 and TT groups 
had significant elevations in SAP, 
DAP, and MAP. Though there were 
no statistically significant differences 
between these two groups, the pattern 
of hemodynamic changes were dis-
tinct. In the TT group, the hemodynam-
ic parameters peaked promptly after 
epinephrine administration, and then 
declined rapidly. The peak levels were 
higher than in the other groups. Those 
in the LMA-6 group increased more 
slowly and reached a plateau later. The 
differences in response presumably 
reflect different speeds of drug absorp-
tion, which are themselves the result 
of differences in the available area for 
absorption. With the LMA route, drug 
absorption occurs partly through the 
laryngeal mucosa and partly through 
the broncho-alveolar mucosa. With the 
TT route, all drug absorption is through 
the broncho-alveolar mucosa.
Niemann et al. reported that epine-
phrine given at standard doses via a 
tracheal tube during cardiac arrest and 
cardiopulmonary resuscitation (CPR) 
was of no benefit. (14) European 
Resuscitation Council CPR guidelines 
recommend epinephrine delivery via 
tracheal tube only as the last resort. 
(15) The onset and the peak pharma-
cological effect of the LMA-6 group 
were slower and lower than in the TT 
group, and cardiac arrest is likely to 
further decrease drug effects. There-
fore, unless higher than six times the 
tracheal dose is given, it is impractical 
to administer epinephrine via the LMA 
in resuscitation scenarios.
Trevisanuto et al. successfully treated 
neonatal respiratory distress syndrome 
by LMA-administered surfactant in 
eight preterm infants. (12) The LMA 
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LMA, laryngeal mask airway; TT, tra-
cheal tube.
Figure 3. Systolic arterial pressure 
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LMA, laryngeal mask airway; TT, tra-
cheal tube.
Figure 4. Diastolic arterial pressure 
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LMA, laryngeal mask airway; TT, tra-
cheal tube.
Figure 5. Mean arterial pressure 
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cheal intubation, such as upper airway 
damage, infection, bradycardia and 
potentially catastrophic tracheal mal-
positioning. For certain drugs where a 
steady plateau effect instead of a high 
peak level is desired, the LMA is still an 
alternative route for drug delivery. How-
ever, given the smaller area of drug 
absorption for the LMA route, doses 
higher than those recommended for 
tracheal administration are likely to be 
required.
There were a number of limitations to 
our study. First, the LMA fitted loosely 
in the pig larynx and leakage of epine-
phrine solution may have occurred, 
compromising interpretation of the 
drug effect. In addition, there was a TT 
in the trachea: although we deflated 
the cuff to reduce occlusion, the TT 
would have impeded dispersion of 
epinephrine into the broncho-alveolar 
area and may have led to an under-
estimate of the effects of LMA-admin-
istered epinephrine. Moreover, drug 
delivery via different airway devices 
involves different degrees of experi-
mental stress, which may have led 
to variable changes of heart rate and 
arterial pressure.
Conclusions
In comparison with standard tracheal 
route, LMA administration of six times 
the standard tracheal dose of epine-
phrine achieved statistically equivalent 
hemodynamic changes. The effects 
achieved via the tracheal route peaked 
sooner but swiftly declined; those of 
LMA route rose more slowly and were 
maintained at a plateau. We could 
not identify an optimal LMA-adminis-
tered epinephrine dose. Doses larger 
than those recommended for trache-
al administration may be needed for 
drugs given via the LMA.
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